Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2001

View Archived Issues

MorphoSys and ImmunoGen expand HuCAL collaboration

Selective VPAC2 receptor agonists hold potential for type 2 diabetes Rx

Very long-acting human insulin analogue presented by Novo Nordisk at ADA meeting

DPP-IV inhibitor improves metabolic control in type 2 diabetes

Safety of single and multiple doses of NBI-6024 demonstrated in type 1 diabetics

AT-1015, a 5-HT2 antagonist, improves nerve blood flow and sensory/motor deficits in diabetic rats

ADA news: preclinical findings support potential of FK-614 in type 2 diabetes

Initiation of phase III trials of TSE-424 triggers milestone payment from Wyeth to Ligand

NN-2211: preclinical and clinical data discussed at ADA scientific sessions

Corixa and Kirin form alliance for therapeutic monoclonal antibodies

Yasmin now available in the U.S.

Atovaquone nanosuspensions have excellent therapeutic efficacy in toxoplasmosis

AstraZeneca's Zomig approved in Japan for migraine

FDA issues nonapprovable letter to Wyeth-Ayerst for long-bone fracture therapy

DepoMed commences phase III trial of Metformin GR for type 2 diabetes

Nortran's antiarrhythmic agent shows oral bioavailability

Kosan Biosciences awarded SBIR grant for epothilone development

UroGenesys changes name to Agensys

NAVIGATOR trial to study nateglinide/valsartan for diabetes and cardiovascular disease prevention

Results for Vasogen's immune modulation therapy to be presented in September

Prous Science launches Integrity --the world's first integrated drug discovery portal

Heterocyclic compounds useful as medicines described by SCRAS

Methods of inhibiting ApoB secretion and/or inhibiting MTP patented by Pfizer

Japan Energy identifies protease inhibitors for HCV

Japanese labs collaborate on discovery of new TPO receptor ligands

Sphingomyelinase inhibitors discovered in natural sources at Kitasato Institute

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...